The anti-inflammatory effect of exercise.
暂无分享,去创建一个
[1] S. Nielsen,et al. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. , 1989, Biochimica et biophysica acta.
[2] B. Saltin,et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. , 2003, The Journal of clinical endocrinology and metabolism.
[3] S. Akira,et al. IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection , 1992, Immunological reviews.
[4] L. Abraham,et al. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. , 1997, Molecular immunology.
[5] A. Steensberg,et al. Plasma interleukin-6 during strenuous exercise: role of epinephrine. , 2001, American journal of physiology. Cell physiology.
[6] P. Patterson,et al. Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury , 1999, Stem cells.
[7] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[8] M. Febbraio,et al. IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle , 2002 .
[9] M. Clark,et al. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. , 2000, Diabetes.
[10] L. Abraham,et al. The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .
[11] N. Secher,et al. Interleukin‐6 release from the human brain during prolonged exercise , 2002, The Journal of physiology.
[12] A. Steensberg,et al. Muscle‐derived interleukin‐6: possible biological effects , 2001, The Journal of physiology.
[13] B. Saltin,et al. Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6 , 2000, The Journal of physiology.
[14] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[15] E. Eldrup,et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes , 2003, Mechanisms of Ageing and Development.
[16] Bente Klarlund Pedersen,et al. Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] J. Davis,et al. Influence of mode and carbohydrate on the cytokine response to heavy exertion. , 1998, Medicine and science in sports and exercise.
[18] T. Valle,et al. The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.
[19] P. Gosling,et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[20] T. van der Poll,et al. Endocrinologic and metabolic effects of interleukin-6 in humans. , 1995, The American journal of physiology.
[21] K. Machida,et al. Exhaustive exercise and type-1/type-2 cytokine balance with special focus on interleukin-12 p40/p70. , 2003, Exercise immunology review.
[22] L. Ferrucci,et al. Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.
[23] N. Secher,et al. Glucose Ingestion Attenuates Interleukin‐6 Release from Contracting Skeletal Muscle in Humans , 2003, The Journal of physiology.
[24] M. Febbraio,et al. Carbohydrate ingestion attenuates the increase in plasma interleukin‐6, but not skeletal muscle interleukin‐6 mRNA, during exercise in humans , 2001, The Journal of physiology.
[25] P. Whincup,et al. Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men , 2002, Circulation.
[26] M. Febbraio,et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. , 2005, American journal of physiology. Endocrinology and metabolism.
[27] K. Feingold,et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. , 1995, Endocrinology.
[28] J. Pankow,et al. Low-grade systemic inflammation and the development of type 2 diabetes mellitus [ndash] : the ARIC Study , 2003 .
[29] B. Pedersen,et al. Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6. , 1997, The American journal of physiology.
[30] K. Ogawa,et al. Exercise induces recruitment of lymphocytes with an activated phenotype and short telomeres in young and elderly humans. , 1999, Life sciences.
[31] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[32] B. Pedersen,et al. The cytokine response to strenuous exercise. , 1998, Canadian journal of physiology and pharmacology.
[33] Alan D. Lopez,et al. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.
[34] S. Coppack. Pro-inflammatory cytokines and adipose tissue , 2001, Proceedings of the Nutrition Society.
[35] C. Dinarello. Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.
[36] M. Laakso,et al. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. , 2003, Diabetes.
[37] M. Billah,et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.
[38] C. Marsh,et al. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. , 1996, Journal of immunology.
[39] G. Hotamisligil,et al. Mechanisms of TNF-alpha-induced insulin resistance. , 2009 .
[40] G. Cline,et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. , 2004, Diabetes.
[41] B. Pedersen,et al. Exercise normalises overexpression of TNF-alpha in knockout mice. , 2004, Biochemical and biophysical research communications.
[42] Roy J. Shephard,et al. Exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in blood mononuclear cells , 2000 .
[43] Katsuhiko Suzuki,et al. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans , 2000, European Journal of Applied Physiology.
[44] C. Dinarello. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. , 2000, The New England journal of medicine.
[45] E. Schleicher,et al. Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB* , 2004, Journal of Biological Chemistry.
[46] A. Brasier,et al. Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. , 1994, Endocrinology.
[47] S. Van Uum,et al. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. , 1995, Journal of applied physiology.
[48] J. M. Lipton,et al. Cytokine antagonists in aged subjects and their relation with cellular immunity. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.
[49] J. Davis,et al. Effects of mode and carbohydrate on the granulocyte and monocyte response to intensive, prolonged exercise. , 1998, Journal of applied physiology.
[50] R. Dobbs,et al. Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .
[51] E. Ford. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. , 2002, American journal of epidemiology.
[52] S. Coppack,et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. , 1999, The American journal of physiology.
[53] M. Netea,et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[54] C. Tsigos,et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. , 1999, Metabolism: clinical and experimental.
[55] P. Macfarlane,et al. The prognostic value of the electrocardiogram in the west of Scotland coronary prevention study , 2002 .
[56] B. Spiegelman,et al. Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* , 1996, The Journal of Biological Chemistry.
[57] B. Pedersen,et al. Supplementation with vitamins C and E inhibits the release of interleukin‐6 from contracting human skeletal muscle , 2004, The Journal of physiology.
[58] U. Smith,et al. Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.
[59] B. Saltin,et al. Does the aging skeletal muscle maintain its endocrine function? , 2004, Exercise immunology review.
[60] L. Christiansen,et al. The IL-6 −174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans , 2004, Experimental Gerontology.
[61] N. Secher,et al. Lymphocytes and NK cell activity during repeated bouts of maximal exercise. , 1996, The American journal of physiology.
[62] L. Old,et al. Tumor necrosis factor (TNF). , 1985, Science.
[63] Bente Klarlund Pedersen,et al. Physical activity and plasma interleukin-6 in humans – effect of intensity of exercise , 2000, European Journal of Applied Physiology.
[64] N. Miyasaka,et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. , 2004, Arthritis and rheumatism.
[65] L. Ferrucci,et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[66] S. Ebrahim,et al. Exercise-based rehabilitation for coronary heart disease. , 2001, The Cochrane database of systematic reviews.
[67] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[68] K. Suzuki,et al. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men , 2002, Diabetologia.
[69] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[70] T. van der Poll,et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.
[71] B. Pedersen,et al. Evidence that interleukin‐6 is produced in human skeletal muscle during prolonged running , 1998, The Journal of physiology.
[72] S. Borst,et al. Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats. , 2002, Metabolism: clinical and experimental.
[73] C. Bruce,et al. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. , 2004, American journal of physiology. Endocrinology and metabolism.
[74] H. Langberg,et al. Substantial elevation of interleukin‐6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans , 2002, The Journal of physiology.
[75] B. Pedersen,et al. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.
[76] C. Dinarello. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. , 1992, Seminars in immunology.
[77] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[78] A. Steensberg,et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. , 2003, Biochemical and biophysical research communications.
[79] B. Pedersen,et al. N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise. , 2000, Journal of applied physiology.
[80] E. Newsholme,et al. Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation , 1996, European Journal of Applied Physiology and Occupational Physiology.
[81] David Carling,et al. The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.
[82] C. Gabay,et al. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. , 1997, The Journal of clinical investigation.
[83] Y. Lacasse,et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.
[84] L Hoffman-Goetz,et al. Exercise and the immune system: regulation, integration, and adaptation. , 2000, Physiological reviews.
[85] G. Paolisso,et al. Advancing age and insulin resistance : role of plasma tumor necrosis factor-a , 1998 .
[86] J. Bülow,et al. Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise , 2002, The Journal of physiology.
[87] Mitchell J. Anderson,et al. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. , 2001, American journal of physiology. Cell physiology.
[88] A. Billiau,et al. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice , 1995, Infection and immunity.
[89] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[90] V. Manganiello,et al. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. , 2002, Diabetes.
[91] B. Saltin,et al. Interleukin‐6 production in contracting human skeletal muscle is influenced by pre‐exercise muscle glycogen content , 2001, The Journal of physiology.
[92] M. Pretolani. Interleukin‐10: an anti‐inflammatory cytokine with therapeutic potential , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[93] J. Davis,et al. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. , 2003, Journal of applied physiology.
[94] E. Sverdlov,et al. Genes coding for RNA polymerase β subunit in bacteria , 1988 .
[95] W. Fiers. Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.
[96] B. Saltin,et al. Searching for the exercise factor: is IL-6 a candidate? , 2004, Journal of Muscle Research & Cell Motility.
[97] J. Polak,et al. Association between physical activity and markers of inflammation in a healthy elderly population. , 2001, American journal of epidemiology.
[98] K. Fallon,et al. The acute phase response and exercise: court and field sports , 2001, British journal of sports medicine.
[99] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[100] P. Schjerling,et al. Chemokines are elevated in plasma after strenuous exercise in humans , 2001, European Journal of Applied Physiology.
[101] M. Schroll,et al. Ageing, tumour necrosis factor‐alpha (TNF‐α) and atherosclerosis , 2000, Clinical and experimental immunology.
[102] F. Green,et al. Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.
[103] E. Bruckert,et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.
[104] G. Krishnaswamy,et al. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. , 1999, JAMA.
[105] J. Mccormack,et al. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. , 2001, Diabetes.
[106] H. Tilg,et al. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.
[107] N. Sattar,et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. , 2002, Diabetes care.
[108] R. Sigal,et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.
[109] H. Northoff,et al. The cytokine response to strenuous exercise. , 1994, International journal of sports medicine.
[110] B. Pedersen,et al. Exercise normalises overexpression of TNF-α in knockout mice , 2004 .
[111] R. Dobbs,et al. Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. , 1999, Acta neurologica Scandinavica.
[112] W. Guggino,et al. Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF. , 2003, American journal of physiology. Cell physiology.
[113] I. Mertens,et al. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. , 2000, International journal of sports medicine.
[114] B. Pedersen,et al. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[115] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[116] M. Kibata,et al. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus , 2001 .
[117] S. Blair,et al. Is physical activity or physical fitness more important in defining health benefits? , 2001, Medicine and science in sports and exercise.
[118] K. Petersen,et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.
[119] Y. Hellsten,et al. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. , 1997, The Journal of physiology.
[120] Peter Schjerling,et al. Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans , 1999, The Journal of physiology.
[121] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[122] J. Hokanson,et al. The Insulin Resistance Atherosclerosis Study Family Study , 2004 .
[123] B. Pedersen,et al. A trauma‐like elevation of plasma cytokines in humans in response to treadmill running , 1998, The Journal of physiology.
[124] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[125] L. Kuller,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. , 2001, Diabetes.
[126] B. Tian,et al. Tumor Necrosis Factor α Stimulates Lipolysis in Adipocytes by Decreasing Gi Protein Concentrations* , 1999, The Journal of Biological Chemistry.
[127] Mutsuo Yamada,et al. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. , 2002, Exercise immunology review.
[128] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[129] S. Akira,et al. Interleukin-6 in biology and medicine. , 1993, Advances in immunology.
[130] J V Castell,et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. , 1988, European journal of biochemistry.
[131] J. Davis,et al. Carbohydrate and the cytokine response to 2.5 h of running. , 1997, Journal of applied physiology.
[132] Roy Taylor,et al. Effects of Tumor Necrosis Factor-α on Insulin Action in Cultured Human Muscle Cells , 2001 .
[133] M. Piepoli,et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.
[134] P. Ridker,et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.
[135] M. Febbraio,et al. Acute interleukin‐6 administration does not impair muscle glucose uptake or whole‐body glucose disposal in healthy humans , 2003, The Journal of physiology.
[136] A. Steensberg,et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[137] M. Kibata,et al. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. , 2001, Diabetes research and clinical practice.
[138] A. Aljada,et al. Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.
[139] M. Schroll,et al. Predicting death from tumour necrosis factor‐alpha and interleukin‐6 in 80‐year‐old people , 2003, Clinical and experimental immunology.
[140] M. Piepoli,et al. Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.
[141] D. Yach,et al. The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.
[142] S. Souza,et al. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. , 1998, Diabetes.
[143] M. Febbraio,et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. , 2004, Diabetes.
[144] G. Paolisso,et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. , 1998, The American journal of physiology.
[145] D. Salamon,et al. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. , 1998, Diabetes research and clinical practice.
[146] R. Ross,et al. Hyperlipidemia and atherosclerosis. , 1976, Science.
[147] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[148] K. Feingold,et al. Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.
[149] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[150] P. Neufer,et al. Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[151] L. Mion,et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. , 1996, Age and ageing.
[152] L. G. Moss,et al. Overexpression of Perilipin A and B Blocks the Ability of Tumor Necrosis Factor α to Increase Lipolysis in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.
[153] M. Febbraio,et al. Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[154] M. Billah,et al. Interleukin-10 inhibits interleukin-8 production in human neutrophils. , 1994, Blood.
[155] A. Brasier,et al. Inhibition of Proteasome Activity Blocks the Ability of TNFα to Down-Regulate Gi Proteins and Stimulate Lipolysis. , 2001, Endocrinology.
[156] Mitchell J. Anderson,et al. Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness , 2004, Diabetologia.
[157] M. Febbraio,et al. Skeletal myocytes are a source of interleukin‐6 mRNA expression and protein release during contraction: evidence of fiber type specificity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[158] P. Savage,et al. Carrying the burden of cardiovascular risk in old age: associations of weight and weight change with prevalent cardiovascular disease, risk factors, and health status in the Cardiovascular Health Study. , 1997, The American journal of clinical nutrition.
[159] A. Mainous,et al. Inflammatory markers and exercise: differences related to exercise type. , 2003, Medicine and science in sports and exercise.
[160] V. Vaccarino,et al. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. , 2002, Archives of internal medicine.
[161] W. Scherbaum,et al. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. , 2001, The Journal of clinical endocrinology and metabolism.
[162] F. Lönnqvist,et al. Mapping of Early Signaling Events in Tumor Necrosis Factor-α-mediated Lipolysis in Human Fat Cells* , 2002, The Journal of Biological Chemistry.
[163] C. Dinarello,et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.
[164] I. Vauhkonen,et al. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. , 2003, Diabetes.
[165] B. Pedersen,et al. Muscle contractions induce interleukin‐6 mRNA production in rat skeletal muscles , 2000, The Journal of physiology.
[166] D. Papanicolaou,et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.
[167] R. Henry,et al. The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.
[168] J. Mei,et al. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. , 2000, The Biochemical journal.
[169] E. O’Neill,et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.
[170] H. Ullum,et al. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. , 1994, Journal of applied physiology.
[171] N. Sattar,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.
[172] Christian Weyer,et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.
[173] B. Pedersen,et al. Immunohistochemical detection of interleukin‐6 in human skeletal muscle fibers following exercise , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[174] Y. Vodovotz,et al. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.